Page last updated: 2024-08-16

rivastigmine and Critical Illness

rivastigmine has been researched along with Critical Illness in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	5 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bozza, FA; do Brasil, PE; Ely, EW; Salluh, JI; Serafim, RB; Soares, M; Tura, BR	1
Honing, ML; Karakus, A; Kesecioglu, J; Kuiper, MA; Roes, KC; Slooter, AJ; Spronk, PE; van der Jagt, M; van der Mast, RC; van Eijk, MM; van Gool, WA	1
Förstl, H; Frölich, L	1
de Pont, AC; Schultz, MJ; van Geer, MA	1
Berg, RM; Möller, K	1

Reviews

1 review(s) available for rivastigmine and Critical Illness

Article	Year
Pharmacologic prevention and treatment of delirium in intensive care patients: A systematic review. Journal of critical care, 2015, Volume: 30, Issue:4 Topics: Antipsychotic Agents; Critical Care; Critical Illness; Delirium; Dexmedetomidine; Haloperidol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypnotics and Sedatives; Intensive Care Units; Length of Stay; Neuroprotective Agents; Postoperative Complications; Quetiapine Fumarate; Respiration, Artificial; Risperidone; Rivastigmine; Treatment Outcome	2015

Article

Year

Pharmacologic prevention and treatment of delirium in intensive care patients: A systematic review.

Journal of critical care, 2015, Volume: 30, Issue:4

Topics: Antipsychotic Agents; Critical Care; Critical Illness; Delirium; Dexmedetomidine; Haloperidol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypnotics and Sedatives; Intensive Care Units; Length of Stay; Neuroprotective Agents; Postoperative Complications; Quetiapine Fumarate; Respiration, Artificial; Risperidone; Rivastigmine; Treatment Outcome

2015

Trials

1 trial(s) available for rivastigmine and Critical Illness

Article	Year
Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial. Lancet (London, England), 2010, Nov-27, Volume: 376, Issue:9755 Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cholinesterase Inhibitors; Critical Care; Critical Illness; Delirium; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Phenylcarbamates; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Failure	2010

Article

Year

Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo-controlled randomised trial.

Lancet (London, England), 2010, Nov-27, Volume: 376, Issue:9755

Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Cholinesterase Inhibitors; Critical Care; Critical Illness; Delirium; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Intensive Care Units; Kaplan-Meier Estimate; Length of Stay; Male; Middle Aged; Phenylcarbamates; Rivastigmine; Severity of Illness Index; Time Factors; Treatment Failure

2010

Other Studies

3 other study(ies) available for rivastigmine and Critical Illness

Article	Year
Cholinesterase inhibitor treatment in patients with delirium. Lancet (London, England), 2011, Mar-12, Volume: 377, Issue:9769 Topics: Cholinesterase Inhibitors; Critical Illness; Delirium; Humans; Phenylcarbamates; Rivastigmine	2011
Cholinesterase inhibitor treatment in patients with delirium. Lancet (London, England), 2011, Mar-12, Volume: 377, Issue:9769 Topics: Aged; Cholinesterase Inhibitors; Critical Illness; Delirium; Humans; Phenylcarbamates; Rivastigmine	2011
Cholinesterase inhibitor treatment in patients with delirium. Lancet (London, England), 2011, Mar-12, Volume: 377, Issue:9769 Topics: Aged; Cholinesterase Inhibitors; Critical Illness; Delirium; Humans; Intensive Care Units; Phenylcarbamates; Rivastigmine; Sepsis	2011